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Bifidobacteria are common and frequently dominant members of the gut microbiota of many 
animals, including mammals and insects. Carbohydrates are considered key carbon sources for the 
gut microbiota, imposing strong selective pressure on the complex microbial consortium of the gut. 
Despite its importance, the genetic traits that facilitate carbohydrate utilization by gut microbiota 
members are still poorly characterized. Here, genome analyses of 47 representative Bifidobacterium 
(sub)species revealed the genes predicted to be required for the degradation and internalization of 
a wide range of carbohydrates, outnumbering those found in many other gut microbiota members. 
The glycan-degrading abilities of bifidobacteria are believed to reflect available carbon sources in 
the mammalian gut. Furthermore, transcriptome profiling of bifidobacterial genomes supported 
the involvement of various chromosomal loci in glycan metabolism. The widespread occurrence of 
bifidobacterial saccharolytic features is in line with metagenomic and metatranscriptomic datasets 
obtained from human adult/infant faecal samples, thereby supporting the notion that bifidobacteria 
expand the human glycobiome. This study also underscores the hypothesis of saccharidic resource 
sharing among bifidobacteria through species-specific metabolic specialization and cross feeding, 
thereby forging trophic relationships between members of the gut microbiota.
Bifidobacteria are Gram positive bacteria with high GC-content genomes that typically reside in the 
gastro intestinal (GIT) tract of various animal species, including warm blooded mammals and social 
insects1,2. Noteworthy, bifidobacteria reach a very high relative abundance as part of the infant gut micro-
biota3-5, and this early life prevalence supports their purported role as modulators of various metabolic 
and immune activities of their host1. Non-digestible carbohydrates derived from the diet, together with 
host-produced glycans found in the mammalian gut represent critical energy sources believed to be 
responsible for the survival and proliferation of many microbial components of the gut microbiota, 
including bifidobacteria6. It is therefore important to know what molecular strategies are employed 
by members of the gut microbiota to harvest and metabolize complex glycans in order to understand 
how they underpin their ecological fitness in, and adaptation to, the GIT environment. Furthermore, 
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carbohydrate metabolism in the mammalian gut may occur in a concerted manner by various members 
of the microbiota, including bifidobacteria7. Thus, carbohydrates are presumed to be partly responsible 
for microbiota dynamics in this changeable environment. Genomics has been crucial in revealing the 
complex interactions and molecular dialogue between a host and its resident (bifido)bacteria, and in 
unraveling bifidobacterial gut colonization strategies8. Recently, all 47 currently recognized bifidobacte-
rial sub/species have been genomically decoded9,10, thus providing the necessary genetic background for 
this group of bacteria. Here, we describe an analysis of the genomes and transcriptomes of representa-
tives of all 47 (sub)species that are currently assigned to the Bifidobacterium genus, predicting bifidobac-
terial genome-based strategies for carbohydrate metabolism that impact on the overall glycobiome of the 
gut microbiota and host, while also being pivotal for the establishment of trophic relationships between 
members of gut microbiota.
Results and Discussion
Genomes of the Bifidobacterium genus and carbohydrate metabolism. Genome sequences 
from the type strain of each of the 47 Bifidobacterium (sub)species (Table S1) were used to assess the 
contribution of carbohydrate metabolism to the corresponding pan-genome, core genome and vari-
ome, determined as described previously9. In total, 18,181 and 551 BifCOGs (Bifidobacterium-specific 
Clusters of Orthologous Genes) represent the pan-genome (pan BifCOGs) and the core of bifidobacte-
rial genomic coding sequences (core BifCOGs) of the Bifidobacterium genus, respectively. Functional 
annotation of the core BifCOGs, based on a recently updated EggNog database11, indicates, as expected, 
that a large part of the conserved core genes encode housekeeping functions and functions involved in 
the adaptation to/interaction with a particular environment, including carbohydrate metabolism (Fig. 
S1). Interestingly, about 5.5% of the core BifCOGs is associated with carbohydrate metabolism (Fig. S1), 
whereas the carbohydrate metabolism functional family is the most represented COG family of the pan 
BifCOGs (13.7%) (Fig. S1). This finding suggests a strong selective pressure towards the acquisition and 
retention of accessory genes for carbohydrate utilization by bifidobacteria in order to be competitive in 
a particular ecological niche. The commitment of bifidobacteria towards the utilization of a wide array 
of simple and complex carbohydrates is further underlined by EggNog profiling of adult human’s faecal 
metagenomes sequenced as part of the Human Microbiome Project (HMP). Results showed that the 
average abundance of the carbohydrate metabolism functional family in HMP metagenomic datasets is 
8.0%, thus being 58% lower than the abundance detected in the bifidobacterial pan-genome, i.e. 13.7% 
(Fig. S1). Notably, the carbohydrate metabolism functional family is the most abundantly represented 
COG family within the Bifidobacterium pan-genome (Fig. S1). The pan-genome analysis also allowed the 
identification of the Truly Unique Genes (TUG), consisting of genes present in just one of the examined 
bifidobacterial genomes (Fig. S1). Interestingly, no functional annotation can be made for the majority 
of TUGs (54.1%) (Fig. S1). However, 13.2% of the identified TUG can be attributed to a COG fam-
ily representing proteins involved in carbohydrate metabolism, including glycosyl hydrolases (GH) and 
carriers for carbohydrate uptake. This data supports the notion that carbohydrate metabolism supports 
adaptation and specialisation processes, and consequently speciation within the Bifidobacterium genus.
Carbohydrate-active enzymes encoded by the genus Bifidobacterium. Considering the impor-
tance of carbohydrate metabolism and energy conversion systems in gut inhabitants such as bifidobacte-
ria, we decided to investigate the presence of genes predicted to encode GHs, polysaccharide lyases (PLs), 
carbohydrate esterases (CE), glycosyl transferases (GT) and carbohydrate binding modules (CBM), and 
other carbohydrate metabolic pathway components using the predicted core- and pan-genome of the 
Bifidobacterium genus. Genomic data showed that B. scardovii and B. biavatii have a significantly larger 
set of genes involved in carbohydrate metabolism, also termed glycobiome12, as compared to other 
bifidobacterial species (Fig. 1). Normalization of GH counts against genome size (Mbp), generating a GH 
index, provided an insight into the relative extent of adaptive events related to carbohydrate metabolism 
found in individual bifidobacterial species. Notably, four species (B. scardovii, B. biavatii, Bifidobacterium 
saeculare and Bifidobacterium dentium) possess a GH index that is approximately 50% higher than the 
bifidobacterial average (Fig.  1). Classification according to the Carbohydrate Active Enzymes (CAZy) 
system13 revealed that the pan-genome of the analysed Bifidobacterium representatives includes 3,385 
genes encoding predicted carbohydrate-active enzymes, including members of 57 GH, 13 GT and seven 
CE families (Fig. 1, Fig. S2 and Fig. S3), while no putative Polysaccharide Lyases (PL)-encoding genes 
were detected. Genes encoding members of CAZy family GH13 are most commonly found in bifidobac-
terial genomes, especially for those bifidobacteria isolated from the mammalian gut (24.2% of the total 
predicted bifidobacterial GH repertoire, Fig. 1). Enzymes belonging to this family are widespread in bac-
teria and are characterized by their degradative abilities towards a wide range of carbohydrates, including 
plant-derived polysaccharides, such as starch and related substrates (amylose and amylopectin and/or 
(cyclo)maltodextrins), and trehalose. Furthermore, stachyose, raffinose and melibiose may also represent 
a target for members of the GH13 family14 and their complete breakdown is achieved with the involve-
ment of GH36 enzymes, which were shown to be abundant in the analysed bifidobacterial genomes 
(Figure S2). Such carbon sources indeed represent very common glycans found in the adult mammalian 
(omnivore and herbivore) diet6. We also observed distinct differences between predicted glycobiomes 
of Bifidobacterium species with regards to their (predicted) ability to degrade plant polysaccharides as 
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opposed to host-derived glycans, such as N- or O-linked glycoproteins, human milk oligosaccharides 
(HMOs) and glycosaminoglycans1. The bifidobacterial glycobiome was shown to contain members of 
GH families that are known to be involved in host-glycan degradation, such as GH33, encompassing 
exo-sialidases, GH29 and GH95, which represent fucosidases, GH20, which include hexosaminidase 
and lacto-N-biosidase activities, GH112, representing lacto-N-biosidases, GH38 and GH125, involv-
ing α -mannosidases as well as GH101 and GH129, which include α -N-acetylgalactosaminidases. 
Interestingly, members of the B. scardovii, B. longum subsp. infantis and Bifidobacterium bifidum species 
possess the most extensive set of such host-glycan-degrading GH families (Fig.  1). Such glycobiome 
specialization probably reflects species-specific adaptation to a particular ecological niche and illustrates 
strict co-evolution with their mammalian host. Clustering of bifidobacterial species based on their pre-
dicted GH and carbohydrate-degradation pathway repertoire (Fig. 1) allows the identification of a cluster, 
designated as GHP/A, representing species with a considerable array of predicted GH43 family enzymes 
involved in degradation of complex plant polysaccharides, such as (arabino)xylan, which plays an impor-
tant structural role as a main constituent of the plant cell wall15, and as such represents a substantial 
component of plant cell wall-derived dietary fiber16. This finding suggests that bifidobacteria rich in 
GH43 member-specifyings genes are adapted to hosts with a vegetarian or omnivore diet. A subgroup 
of the cluster GHP/A, named GHP/A1, appears to possess a wider array of GHs (Fig. 1). This subgroup 
encodes a large number of GH3 family enzymes that are predicted to be involved in the degradation 
of an extensive range of plant-derived polysaccharides (e.g., cellodextrin, (arabino)xylan and (arabino)
galactan), as well as involved in bacterial cell wall biosynthesis and turnover. Notably, bifidobacterial 
species isolated from honey/bumblebees specify a peculiar GHP/C cluster, whose members possess a 
Figure 1. Predicted glycobiome of the Bifidobacterium genus and some additional members of the 
Bifidobacteriaceae family. GH families and carbohydrate-utilization pathways profiles, based on CAZy 
database and Pathway-tools software, respectively, were used to construct a hierarchical clustering of all 
tested species of the Bifidobacterium genus and additional members of the Bifidobacteriaceae family. This 
clustering highlights the presence of three distinct clusters named GHP/A, GHP/B and GHP/C that display a 
different repertoire of GHs as well as a different repertoire of plant carbohydrate degradation pathways. GH 
arsenal prediction for every analyzed Bifidobacteriaceae species is represented by a bar plot. The presence of 
pathways for degradation of simple or complex carbohydrates is represented by the red color in the heat map 
and the GH index (the number of GHs predicted in each genome normalized by genome size expressed as 
Mbp) is illustrated as an orange bar plot. Pathways denominations are indicated as follows: 1 Bifidobacterium 
shunt, 2 galactose degradation I (Leloir pathway), 3 melibiose degradation, 4 ribose degradation, 5 lactose 
degradation III, 6 glycogen degradation I, 7 glycogen degradation II, 8 sucrose degradation IV, 9 L-arabinose 
degradation I, 10 xylose degradation I, 11 D-mannose degradation, 12 (1,4)-ß-xylan degradation, 13 starch 
degradation V, 14 chitin degradation (chitinase), 15 trehalose degradation IV, 16 Pectin (homogalacturonan) 
degradation, 17 2'-deoxy-α-D-ribose 1-phosphate degradation, 18 trehalose degradation I (low osmolarity), 
19 L-rhamnose degradation II.
www.nature.com/scientificreports/
4Scientific RepoRts | 5:15782 | DOi: 10.1038/srep15782
discrete set of GH43 and GH3 enzymes, but in addition these particular bifidobacterial genomes are 
predicted to encode a very limited repertoire of GH13 representatives, in contrast to all other bifidobac-
teria. This is in accordance with the absence or paucity of carbohydrates with α -glucosidic linkages in the 
honey/bumblebee diet17. The remaining bifidobacterial species, not fitting in clusters GHP/A or GHP/C, 
are included in cluster GHP/B, which is characterized by an under-representation of GH43 and GH3.
In order to further evaluate the importance of the bifidobacterial contribution to degradation of 
complex carbohydrates found in the human gut, we compared the bifidobacterial GH repertoire with all 
the so far sequenced members of the human gut microbiome18,19. For this purpose, we used GH data of 
2,674 genomes available in the CAZy database13 with the addition of data obtained from the bifidobac-
terial genomes analysed in this study. Interestingly, the Bifidobacterium genus was shown to specify one 
of the largest arsenal of GH13, GH43, GH3 and GH51 family members (2.0 fold-, 2.6 fold-, 5.8 fold-, 
7.0 fold-, respectively, more with respect to the average GH arsenal of the gut microbiome), along with 
Bacteroides spp. (Bacteroidales family) and Clostridiales family. Furthermore, abundance of these GH 
families has been shown by a small number of other members of the gut microbiota such as Paenibacillus 
spp. (Bacillales family) and Streptomyces spp. (Actinomycetales family) (Fig. 2). These findings corroborate 
the very substantial contribution to glycan-breakdown potential by bifidobacteria in the mammalian gut.
Secreted glycosyl hydrolases of bifidobacteria. In order to allow GH enzymes produced by dif-
ferent organisms to act in concert and to access glycans with a degree of polymerization exceeding that 
of the corresponding uptake system, certain GH enzymes are expected to be located on the cell surface 
or secreted into the environment. Notably, even though the majority of the identified GH enzymes from 
the bifidobacterial pan-genome is predicted to be intracellular, 10.9% of the deduced bifidobacterial 
GH pool is predicted to be extracellular, of which 32.9% are members of the GH13 family and anno-
tated as pullulanases and α -amylases, 24% are members of the GH43 family and predicted to act as 
β -xylosidases and α -L-arabinofuranosidases, while 12% are members of the GH51 family and classified 
as α -L-arabinofuranosidases. These data suggest that bifidobacteria secrete a relevant pool of GH for the 
degradation of plant polysaccharides, which would accordingly represent an important resource for the 
host in the context of obtaining access to dietary fibres. The secreted bifidobacterial pan-genome also 
encompasses GHs involved in host-glycan degradation (see above), being classified as families GH29, 
GH33, GH95 and GH101, and constituting 0.4%, 3.5%, 0.8% and 2.7% of this secreted pan-genome, 
respectively. Predicted extracellular GHs were identified in 43 species of the genus Bifidobacterium, with 
a particularly high prevalence in B. biavatii (endowed with 17 secreted GHs, including 4 GH43 and 4 
Figure 2. Comparative analysis of bifidobacterial GHs against other gut bacteria. The central heat map 
shows GH prediction data of 2721 sequenced bacterial strains belonging to bacterial orders residing in the 
human gut, identified by different color codes as explained in the underlying table. The four heat map rows, 
situated above the main heat map, represent an enlarged view of the GH51, GH3, GH43 and GH13 content. 
Data regarding Bifidobacteriales are highlighted in blue. Data regarding Clostridiales and Bacteroidales are 
highlighted in green.
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GH13 members), B. scardovii (endowed with 11 secreted GHs, including 3 GH43 and 3 GH51, annotated 
as α -L-arabinofuranosidases) and B. bifidum (endowed with 11 secreted GHs, including two GH84 and 
two GH33 members, predicted to act as N-acetyl β -glucosaminidases and sialidases, respectively). The 
remaining bifidobacterial genomes are predicted to encode seven or less secreted GHs. The two secreted 
N-acetyl β -glucosaminidases and the two secreted sialidases found in B. bifidum are crucial for the uti-
lization of HMOs and intestinal glycoconjugates such as mucin, thus further supporting the notion that 
this microorganism is highly adaptated to colonize and persist in the mammalian gut20,21. Nevertheless, 
B. bifidum is unable to use sialic acid as its sole carbon source and the activity of sialidases appears to be 
important only to allow access to other carbohydrates associated to sialylated host-encoded glycans20,21. 
Furthermore, the released sialic acid can be utilized by other bifidobacteria, such as B. breve, resulting in 
cross-feeding between bifidobacterial species that share the same ecological niche20,21.
Saccharolytic pathways of bifidobacteria. Predictions of complete pathways for the degradation of 
simple (di/trisaccharides) and complex sugars through Pathway Tools software22 showed that B. biavatii  
specifies the largest number of such pathways (14 complete pathways) (Fig. 1), while the predicted rep-
ertoire for carbohydrate degradation of B. bombi, Bifidobacterium crudilactis, B. longum subsp. infantis, 
B. minimum and Bifidobacterium ruminantium is limited to just nine pathways (Fig. 1). Notably, when 
assessing presence/absence data of pathways involved in the breakdown of simple and complex car-
bohydrates shown in the GHP clustering profile (Fig.  1), bifidobacterial species isolated from honey/
bumblebees, constituting cluster GHP/C (Fig. 1), lack genes encoding glycogen degradation I and gly-
cogen degradation II pathways. Based on recent discoveries, glycogen metabolic pathways are present 
in bacterial species able to face diverse environments and showing a flexible lifestyle23. More recently, it 
was reported that the ability of Lactobacillus acidophilus to synthesize and store energy in the form of 
glycogen, either prior to or during its transit through the host, potentially confers a competitive advan-
tage in the GI tract24. This is supported by the fact that glycogen storage is ubiquitous among enteric 
bacteria, possibly due to the necessity to support rapid growth in the intestinal environment where 
there is intense trophic competition25. On the other hand, it was hypothesized26 that the loss of glycogen 
pathways is a strong indication of genome degradation associated with parasitic or symbiotic behaviour 
of bacteria. Though the original study of Henrissat et al. was based on the analysis and comparison 
of just 55 fully sequenced bacterial genomes, their findings have more recently been substantiated by 
others involving 1202 bacterial proteomes23. Among Bifidobacteriaceae, it is noteworthy that B. actinoco-
loniiforme, B. asteroides, B. bohemicum, B. bombi, B. coryneforme and B. indicum, species isolated from 
insects and constituting the GHP/C cluster, show a smaller genome size compared to all other bifido-
bacterial species isolated from mammals. We therefore speculate that Bifidobacterium members linked to 
insects have enjoyed a longer adaptation history to their hosts, in evolutionary terms, because mammals 
appeared on earth in the late Paleocene (between 65 and 23 mya), whereas insects in the Devonian period 
(between 459 and 359 mya) or even before according to a recent phylogenomics study27. This hypothesis 
is confirmed by comparison of the phylogenetic supertree of all known bifidobacterial species and that 
obtained for their corresponding hosts, revealing a co-evolution host-microbe profile (Fig. S4).
The genomes of B. asteroides, B. actinocoloniiforme, B. indicum, B. coryneforme, B. bombi and B. 
bohemicum possess a complete trehalose degradation IV pathway, which is absent in the majority of the 
other bifidobacteria and in all other examined members of the family Bifidobacteriaceae. The acquisition 
of this pathway, which is apparently specific for bifidobacterial species isolated from the insect gut, may 
be related to the fact that trehalose is used as carbohydrate storage and blood-sugar by many insects 
including bees28. Remarkably, a large majority of bifidobacterial genomes included in cluster GHP/B do 
not encompass pathways for L-arabinose and/or xylose metabolism (Fig. 1). These genomes encode rela-
tively few GH43 enzymes compared to the GHP/A and GHP/C clusters, thus confirming a strict genetic 
adaptation to ecological niches where these plant carbohydrates are not available. The ecological origin 
of most of the GHP/B members that do not possess L-arabinose and/or xylose degradation pathways is 
either raw/fermented milk or faecal material/gastrointestinal tract of suckling animals (Table S1), where 
a milk-based diet represents the main nutrient retrieval opportunity. In this context, B. breve, B. bifidum 
and B. longum subsp. infantis have been isolated from infants, B. thermacidophilum subsp. porcinum 
and B. choerinum from piglet, B. crudilactis from raw bovine milk and B. mongoliense from fermented 
mare’s milk (Table S1), thus suggesting that these species have evolved to focus solely or predominantly 
on the degradation of carbon sources present in milk and have lost or did not acquire the ability to use 
(certain) plant polysaccharides. Fermented milk is a strict anthropogenic environment and these bacteria 
are unlikely to have evolved in fermented milk per se. In fact, the natural ecological environment of these 
species is still expected to be the gut from various (suckling) animals. In this environment such bifidobac-
terial taxa have enjoyed the presence of a rich reservoir of milk-based carbohydrates (oligosaccharides/
lactose), which thus caused their genomes to acquire a genetic arsenal that allowed them to access these 
carbon sources. In contrast, B. ruminantium and B. boum taxa have been isolated from the bovine rumen 
(Table S1), an environment rich in plant polysaccharides, although they lack GH43-encoding genes and 
consequently cluster in GHP/B. Other rumen-derived bifidobacteria do encode GH43 enzymes, perhaps 
indicating that certain bifidobacteria rely on cross-feeding, which is in line with bifidobacteria being a 
minor component of the rumen microbiota, although their functional role is largely unknown. B. breve 
deserves a special mention as this species seems to have adopted a non-specialist strategy of acquiring 
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constituent elements of both plant- and host-derived carbohydrates (consistent with its isolation from 
both infants and adults), yet is lacking the ability to directly access (many) HMOs, or mucin, nor possess-
ing the ability to metabolize xylose/arabinose-containing carbohydrates, though it can metabolize a wide 
range of α /β -glucose- and α /β -galactose-containing sugars14,20. Thus, it may, perhaps co-operatively, rely 
on other (bifido)bacterial species like B. bifidum or B. longum subsp. infantis in order to sustain growth 
on the above mentioned complex sugars29.
Carbohydrate utilization patterns of Bifidobacterium. Fermentation profiles of the 47 sequenced 
Bifidobacterium strains revealed that all strains are able to ferment a common set of sugars, which include 
glucose, sucrose and raffinose (Fig. S5, panel a). In contrast, fermentation capabilities for other sugars, 
such as lactose, galactose, maltose, melibiose, fructose, lactulose, maltodextrins, turanose, β -gentibiose 
and xylose, were shown to be variable for the majority of the strains tested (Fig. S5, panel a). Notably, 
we identified bifidobacterial taxa such as B. cuniculi displaying an ability to grow on a wide range of 
simple and complex carbohydrates (Fig. S5, panel a), thus suggesting metabolic expansion of its car-
bohydrate acquisition abilities perhaps to enhance competitiveness in one or more ecological niches. 
In contrast, other bifidobacterial species, such as Bifidobacterium animalis subsp. animalis, only utilize 
a relatively small number of the carbohydrates assayed here (Fig. S5, panel a), an observation which, 
together with the very limited number of predicted GHs/carbohydrate pathways encoded by this taxon 
(Fig.  1), underlines a rather high level of genetic adaptation to an ecological niche. Growth studies 
highlighted the existence of different carbon sources that are differentially utilized by bifidobacteria, 
in a manner consistent with our predictions. In this context growth experiments involving most mem-
bers of the B. asteroides phylogenetic group showed that they do not exhibit any appreciable growth 
on glycogen, an observation which is consistent with in silico pathway predictions. Cultivation trials 
performed on plant-derived carbohydrates such as arabinose or xylose revealed that these sugars are 
utilized by a majority of the bifidobacteria tested except for those taxa that form the GHP/B cluster 
(Fig.  1), which are not predicted to encode enzymes of the L-arabinose degradation I and xylose deg-
radation I pathways. The ubiquitous monosaccharide mannose that is found in both plant and ani-
mal glycans, is easily shunted into the glycolytic pathway via isomerization of mannose-6-phosphate to 
fructose-6-phosphate30. Growth on mannose is, however, not a wide-spread property among the tested 
bifidobacterial taxa, a finding that is consistent with genomic data (Fig.  1), which revealed a variable 
distribution of genes supporting bifidobacterial mannose utilization such as genes encoding predicted 
mannosidases and mannose-6-phosphate isomerases. Interestingly, when mannosidase-encoding genes 
were detected, they were in the large majority of cases shown to be located within a putative N-glycan 
(host-derived) degradation cluster. Lactose constitutes a typical glycan that specifically occurs in the 
mammalian diet, though normally limited to the early stages of life31. In silico analyses involving the 
genomes of 47 bifidobacterial taxa revealed a ubiquitous distribution in their chromosomes of genes 
encoding β -galactosidases. This finding suggests a rather wide-spread utilization of lactose as well as 
other galactose-containing glycans such as galactan, galacto-oligosaccharides, Human milk oligosaccha-
rides (HMO) and mucin, which require particular β -galactosidases for their degradation, among mem-
bers of the Bifidobacterium genus20,32. Growth experiments involving lactose showed that, except for B. 
ruminantium and B. thermacidophilum subsp. thermacidophilum, all other tested bifidobacteria are able 
to ferment this disaccharide. In contrast, in silico analyses suggested that L-rhamnose is rarely used by 
bifidobacteria due to the apparent lack of genes encoding L-rhamno-gamma-lactonase, L-rhamnoate 
dehydratase and 2-keto-3-deoxy-L-rhamnoate aldolase. Notably, fermentation profiles involving this car-
bon source confirmed that only B. biavatii is able to ferment L-rhamnose. Furthermore, we evaluated 
the abilities of members of the genus Bifidobacterium to utilize typical host glycans like mucin and 
HMO. Interestingly, in addition to the currently known bifidobacterial archetypes that can utilize these 
host-glycans (B. bifidum and B. longum subsp. infantis)20,33, we identified that B. biavatii, B. crudilac-
tis, B. kashiwanohense, Bifidobacterium stellenboschense and Bifidobacterium mongoliense are all capable 
of HMO metabolism. Inspection of their genome sequences revealed the presence of genes predicted 
to encode sialidases, fucosidases, N-acetyl-β -hexosaminidases, endo-α -N-acetylgalactosaminidase and 
β -galactosidases, which have previously been shown to be crucial for the breakdown of these complex 
carbohydrates20,33. This further illustrates the broad catabolic abilities of bifidobacteria in general and in 
particular their specialization to utilize complex carbohydrates that are commonly found in the (infant) 
mammalian GIT.
In order to substantiate the notion that bifidobacterial genomes contain specific genes responsible 
for the utilization of key carbohydrates that are present in their ecological niches and correspond to 
their saccharolytic phenotype, we investigated the transcriptome for a representative bifidobacterial spe-
cies for each of the seven bifidobacterial phylogenetic clusters described previously10 grown on (where 
possible) glucose, glycogen, lactose, xylose, rhamnose, mannose, trehalose or HMO as the sole carbon 
source (Fig. S5, panel b). RNAseq experiments allowed the identification of the transcriptomes for each 
bifidobacterial strain tested in cases where growth was obtained, revealing that the carbohydrate metab-
olism COG family [COG category (G)], is one of the most represented in the transcriptomes (Fig. S5, 
panel c). Manual inspection of the identified transcriptomes highlighted the existence of a large arsenal 
of genes encoding GHs and other enzymes that constitute parts of carbohydrate metabolic pathways, 
including suspected carbohydrate carrier systems that are expressed when bifidobacteria are cultivated 
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on a carbohydrate (Fig. S6). In this context, we identified β -galactosidases of the GH2 and GH42 families 
that were shown to be expressed when bifidobacteria are grown on lactose, as well as MFS and ABC 
systems predicted to act as carriers for lactose and/or glucose and/or galactose (Fig. S6). Cultivation of 
bifidobacteria on mannose, rhamnose, trehalose or xylose resulted, in cases where growth was observed, 
in the transcription of genes encoding specific catabolic pathways such as D-mannose degradation, 
L-rhamnose degradation II, trehalose degradation I and xylose degradation I (Fig. S6), observations that 
are consistent with our in silico assignments. The transcriptomes of bifidobacteria grown on glycogen 
clearly showed that transcription of genes encompassing the glycogen degradation I pathway, predicted 
to be indispensable for glycogen to glucose breakdown, is switched on under these circumstances (Fig. 
S6). The only exceptions are represented by the transcriptomes of Bifidobacterium pseudocatenulatum 
and B. stellenboschense in which the genes predicted to specify amylomaltase and glucokinase enzymes 
are not expressed, suggesting the existence of an alternative pathway for conversion of the intermedi-
ate carbohydrate maltose into β -D-glucose-6-phosphate. Transcriptomic data recovered from growth 
of B. biavatii on the complex substrate HMO revealed up-regulation of a sizable number of different 
GH-encoding genes, such as those predicted to belong to GH1 (predicted β -D-fucosidases), GH2 (puta-
tive β -galactosidases), GH3 (putative β -N-acetylhexosaminidases), GH29 (α -L-fucosidases), GH30 (pos-
sible β -fucosidases), GH36 (likely α -N-acetylgalactosaminidases), GH42 (putative β -galactosidases), 
GH85 (endo-β -N-acetylglucosaminidases) and GH112 (predicted galacto-N-biose/lacto-N-biose phos-
phorylases) (Fig. S6). Other up-regulated GH-coding genes included those specifying members of GH13, 
GH32 and GH43 families, even though their predicted enzymatic activities do not appear to be directed 
against HMO.
Mutualistic/commensal breakdown activities of bifidobacteria on carbohydrates. In gut 
ecosystems, bacteria can exploit mutualistic as well as commensal and competitive activities during 
metabolism of various carbon sources available in such an environment. Thus, we were interested to 
evaluate possible trophic relationships towards carbohydrates between bifidobacterial taxa found in 
various ecological niches. Specific bi-association of bifidobacterial taxa were selected based on their 
common ecological origin (e.g., human-, porcine-, or rabbit-gut). Their growth performances on car-
bon sources that are commonly available in their particular ecological niche were assayed during 
co-cultivation (bi-association) and compared to those achieved when the strains were grown separately 
(mono-association). Such trials suggested that when cultivated together these bifidobacterial taxa were 
taking an evident benefit as supported by the enhanced cell densities in the bi-associations compared to 
the mono-associations (Fig. 3). These growth-benefits were in a few cases evident for both strains such 
as in the case of the B. magnum and B. cuniculi combination when these strains were cultivated on xylan 
or on starch (Fig. 3). Such findings were further supported by the evaluation of transcriptomic changes, 
employing an RNAseq approach, observed for these bifidobacterial strains when cultivated together 
as compared to the situation where these strains were assayed separately. Notably, in bi-associations 
where a benefit was noticed in terms of cell numbers for both strains, such as for B. magnum and B. 
cuniculi cultivated on starch, complementarity in terms of the transcription of the genetic repertoire 
for the metabolism of this complex sugar was observed for these strains. In fact, under such conditions 
the alpha-glucoside phosphorylase-specifying genes, i.e. BMAGN_0016 and BCUN_1467, as well as 
amylase-encoding genes, i.e. BMAGN_0612 and BCUN_0313, of both B. magnum and B. cuniculi were 
shown to be transcribed (Fig. 3). Interestingly, while these latter enzymes are predicted to be intracellular, 
two genes encoding putative extracellular pullulanases (BCUN_0354 and BCUN_0356), were shown to 
be transcribed. Even though the detected transcription level for these genes was low, it may be that such 
enzymes allowed a partial de-branching of starch so as to allow internalization of the released degrada-
tion products into the bacterial cell for complete degradation. The resulting starch-degradation products 
such as maltose and alpha-glucosides are presumed to be internalized by means of ABC transporters 
(BMAGN_0006-BMAGN_0009 and BCUN_2019-BCUN_2022) and/or PTS systems (BMAGN_0338 
and BCUN_1552), of which the corresponding genes were shown to exhibit increased transcription 
(2.37 fold and 10.42 fold with p < 0.001, respectively) relative to mono-association conditions (Fig.  3). 
Thus, on this substrate both strains appear to co-operate in order to achieve starch degradation thanks 
to the collective action of their extracellular amylases, perhaps resulting in the production of a larger 
amount of starch-derivatives compared to that achieved when the strains are cultivated separately on this 
substrate. In contrast, when these strains were co-cultivated on xylan, we only noticed an up-regulation 
of the gene encoding a beta-xylosidase (BCUN_1638) in B. cuniculi. Similarly, B. cuniculi exhibited a 
modest transcriptional upregulation of the genes specifying the putative uptake and degradation machin-
ery for xylose (BCUN_0705-BCUN_0707 and BCUN_1645), whereas B. magnum showed no modula-
tion in the beta-xylosidase-encoding gene, yet down-regulation of genes involved in xylose transport. 
The latter findings suggest that B. magnum modulates gene expression in order to support growth of B. 
cuniculi and allows this latter strain to participate in xylan degradation and harvesting of the deriving 
xylose. Since none of these enzymes are predicted to be extracellular, an alternative explanation for this 
behavior is partial degradation of xylan to xylo-oligosaccharides during media preparation. These deg-
radation products can be the target for specific uptake transporters, allowing their complete breakdown 
inside the bacterial cells. Another scenario was noticed for the co-cultivation of B. stellenboschense and 
B. biavatii grown in the presence of glycogen, where only the latter strain seems to take advantage of 
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the presence of the other strain (Fig.  3). In fact, under these circumstances B. biavatii substantially 
enhanced transcription of various genes encoding enzymes predicted to be involved in the hydrolysis 
of glycogen such as predicted glycosyl hydrolases of the GH13 and GH77 families, as well as a glycogen 
phosphorylase (Fig.  3). In contrast, B. stellenboschense did not reveal any transcriptional modulation 
of genes with predicted functions in glycogen utilization when the strains were co-cultivated (Fig.  3). 
Similarly, data concerning co-cultivation of B. longum subsp. suis and B. thermacidophilum subsp. por-
cinum on starch is also consistent with a cross-feeding scenario. In fact, under these growth conditions, 
qPCR assays revealed that cell numbers of B. longum subsp. suis are enhanced (≥ 2 fold) with respect to 
those noticed when this strain was cultivated on its own on this substrate. Furthermore, transcriptome 
analyses revealed a significant induction (≥ 8 fold, p < 0.001) of genes encoding a complete ABC system 
involved in the up-take of maltose, which is a starch-derived glycan, of B. longum subsp. suis when grown 
with B. thermacidophilum subsp. porcinum in the presence of starch as the sole carbon source (Fig. 3). 
In contrast, even though the B. thermacidophilum subsp. porcinum genome is predicted to encode a 
Figure 3. Evaluation of possible bifidobacterial cross-feeding by a transcriptomics approach. (Panel a) 
reports the abundance, observed through quantitative qRT-PCR, of eight bifidobacterial species cultivated in 
MRS supplemented with four different carbohydrates. These species were either grown on their own (mono-
association) or in the presence of another bifidobacterial strain (bi-associations) sharing the same ecological 
niche. The five case studies analysed are named progressively with letters from A to D, corresponding to: B. 
cuniculi and B. magnum grown on starch (A), B. cuniculi and B. magnum grown on xylan (B), B. biavatii 
and B. stellenboschense grown on glycogen (C) and B. thermacidophilum subsp. porcinum and B. longum 
subsp. suis grown on starch (D). (Panel b) shows the transcriptional fold change of genes encoding enzymes 
in the breakdown of glycans observed in the five case studies, named progressively with letters from A to 
D. Functional annotation of enzymes are indicated in orange while the functional annotation of transporter 
encoding genes and the predicted glycan specificity is highlighted in green.
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secreted GH13 family enzyme (BPORC_0608), the transcription of genes predicted to be involved in 
starch metabolism of B. thermacidophilum subsp. porcinum did not appear to be affected by the presence 
of B. longum subsp. suis (Fig. 3).
Overall, our findings suggest that bifidobacteria access carbohydrates that are commonly present in 
their ecologic niches employing trophic interactions that may vary from commensalism to mutualistic. 
Furthermore, these concerted breakdown activities may similarly exert positive effects on other members 
of the gut microbiota and thus promote an expansion of the gut glycobiome.
Bifidobacteria and mammalian gut adaptation. Bifidobacteria have predominantly been iden-
tified in the GIT of mammals1. However, their functional contribution to the microbiota residing in 
this body compartment has not been thoroughly investigated. We therefore looked for the presence of 
GH-encoding bifidobacterial DNA sequences among 44 out of 136 available gut metagenome data sets 
Figure 4. Data mining for bifidobacterial GH genes and bifidobacterial pathways for carbohydrate 
degradation in adult and infant fecal metagenome data sets and an infant fecal metatranscriptome 
data set. Bar plots above the heatmaps show the relative abundance of bifidobacteria in the analysed 
samples. Heatmaps in the upper part depict the coverage obtained by alignment of adult and infant fecal 
metagenomic data sets, or infant metatranscriptome data sets to predicted bifidobacterial GH-encoding 
genes. In order to compare results for datasets with different sizes, all coverage values were normalized 
as obtained from a 10 million read dataset. Heatmaps in the lower part of the image represent the 
coverage obtained by alignment of the same datasets to genes constituting the bifidobacterial pathways 
for carbohydrate degradation. Relevant GH genes and pathways involved in the metabolism of glycans are 
highlighted in red. Pathways designations are identical to those indicated in Fig. 1.
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from healthy adults, enrolled in the Human Microbiome Project19 that had shown consistent presence 
of bifidobacteria based on MetaPhlAn profiling34, as well as in nine metagenomes and related meta-
transcriptomes of healthy infant gut microbiota, sequenced by the Broad Institute (NCBI bioproject ID 
63661). The coverage of each gene included in the bifidobacterial pangenome was computed based on 
the metagenomic reads with >98% full-length identity. As displayed in Fig.  4, the average abundance 
of Bifidobacterium genes ranged from 0.2% to 35.9%, with a distinctly higher prevalence of bifidobac-
teria in the faecal metagenomes from infants. This is consistent with the catabolic potential for HMOs. 
Interestingly, among the most frequently represented bifidobacterial genes in the metagenomic data sets 
from adult, the presence of an extensive repertoire of GH-encoding genes, such as those specifying 
GH3, GH13, GH43, GH51 and GH77 (involved in the breakdown of complex plant carbohydrates), is 
noteworthy (Fig. 4). Such findings reinforce the notion that despite the relative paucity of bifidobacte-
ria detected in the adult human gut, their functional contribution to the human gut microbiome may 
be important in terms of expanding the overall glycobiome of the large intestine, thereby affecting the 
overall gut physiology. Furthermore, in the metagenome datasets from infants the relatively high bifido-
bacterial abundance is also reflected by the prevalence of bifidobacterial GH-encoding genes, such as 
those specifying members of the GH2, GH20, GH29, GH33, GH36, GH42, GH84, GH95, GH101 and 
GH112 families, involved in the degradation of milk-related carbohydrates such as lactose and HMOs, 
as well as in mucin degradation (Fig.  4). Notably, GH-specifying genes encoding β -hexosaminidases, 
lacto-N-biosidases, galacto-N-biose/lacto-N-biose phosphorylases, α -L-fucosidases, sialidases, neurami-
nidases, N-acetyl β -glucosaminidases, hyaluronidases and endo-α -N-acetylgalactosaminidases are not 
widespread in adult metagenomes (Fig. 4). Availability of metatranscriptomes corresponding to the ana-
lysed infants’ metagenomes revealed pronounced transcription of the bifidobacterial GH gene predicted 
to be involved in milk, HMO and mucin degradation (Fig. 4), clearly supporting the key functional roles 
exploited by these GHs in the infant gut microbiota.
To further elucidate the functional contribution of bifidobacteria to the human microbiota we screened 
the metagenomic and metatranscriptomic datasets for the presence of genes encompassing carbohydrate 
degradation pathways that had been predicted to be present in the bifidobacterial pan-genome (Figs 1 
and 4). Both the adult and infant metagenomes showed a high abundance of genes for the Bifidobacterium 
phosphoketolase-dependent, or so-called bif shunt, pathway, as expected, as well as genes involved in 
galactose degradation I, melibiose degradation, lactose degradation III, glycogen degradation I, glycogen 
degradation II and sucrose degradation IV pathways (Fig. 4), accompanied by presence of genes involved 
in starch degradation V, arabinose degradation I, xylan degradation and xylose degradation I pathways. 
The presence of such pathways illustrates their presumed importance for adaptation of bifidobacteria to 
the human gut environment. Interestingly, the infant’s metatranscriptomic datasets correspond to the 
presence of the bif shunt (as expected) and pathways for galactose, lactose, glycogen and sucrose deg-
radation, while no or low transcriptional activity was detected that corresponded to catalytic pathways 
for the plant polysaccharides arabinose, xylan and xylose (Fig. 4), reflecting the paucity of these carbo-
hydrates in an infant’s diet.
Conclusions
Bifidobacteria may be considered as key representatives of the mammalian gut microbiota, especially 
during the first phase of their host’s life. However, very little is known about their genetic strategies 
to colonize and persist within the gut, and to get access to the nutrients available in this environment. 
The current study highlights the very extensive saccharolytic features displayed by members of the 
Bifidobacterium genus, revealing how these bacteria metabolize specific carbohydrates available in their 
particular ecological niche. Comparison of the glycobiome identified in the genus Bifidobacterium with 
those identified in other members of the human gut microbiota revealed their unique and important 
contribution in terms of GHs involved in the breakdown of complex plant carbohydrates such as arab-
inoxylan, galactan and starch. The impact of bifidobacteria in the breakdown of dietary carbohydrates 
is also crucial for the establishment and reinforcement of trophic relationships between members of the 
gut microbiota. In fact, both mutualistic as well as commensal interactions in the mammalian gut can 
be carbohydrate-driven6,7. Here, we have shown how a simple bifidobacterial community may co-operate 
between themselves as well as with other members of the gut microbiota in the utilization of specific 
glycans, commonly available in the mammalian gut, by means of cross-feeding activities so as to provide 
growth benefits to one or both members of such a community as well as with the other members of 
the gut microbiota. Such findings support the concept of the existence of a social intelligence of bifido-
bacterial communities in the harvesting and metabolism of glycans available in their ecological niches, 
which regulate the dynamics of the gut microbiota relationships. However, it is reasonable to expect 
that in much more complex microbial communities such as those identified in the mammalian gut, 
cross-feeding activities as exemplified by bifidobacteria also involve other members of the gut microbi-
ota, perhaps generating an even larger beneficial effect. A survey of human gut metagenomic datasets, 
representing both adult and infant samples, revealed that, notwithstanding their relatively low abundance 
in adults, the functional contribution of bifidobacteria to the enzymatic arsenal directed at degradation of 
complex carbohydrates is relevant. In this context, the expansion of the GH repertoire dedicated to the 
metabolism of infant dietary sugars, such as HMOs, as well as mucin is noteworthy. Another clear sign 
of advanced bifidobacterial adaptation to its mammalian host is represented by the identification in a 
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small number of bifidobacterial taxa which include B. bifidum, B. longum subsp. infantis20,33, as well as B. 
biavatii, B. crudilactis, B. kashiwanohense, B. stellenboschense and B. mongoliense, of metabolic repertoires 
involved in the breakdown of host-derived glycans such as HMOs and mucin.
Materials and Methods
Bacterial strains, growth conditions. All Bifidobacterium strains were cultivated in an anaer-
obic atmosphere (2.99% H2, 17.01% CO2 and 80% N2) in a chamber (Concept 400, Ruskin) on De 
Man-Rogosa-Sharp (MRS) broth (Scharlau Chemie, Barcelona, Spain) supplemented with 0.05% (w/v) 
L-cysteine hydrochloride and incubated at 37 °C. Cell growth on semi synthetic MRS medium sup-
plemented with 1% (wt/vol) of a particular sugar was monitored by optical density at 600 nm using a 
plate reader (Biotek, Vermont, USA). The plate reader was run in discontinuous mode, with absorbance 
readings performed in 60 min intervals, and preceded by 30 sec shaking at medium speed. Cultures were 
grown in biologically independent triplicates and the resulting growth data were expressed as the mean 
of these replicates. Carbohydrates were purchased from Sigma (Milan, Italy) or Carbosynth (Berkshire, 
UK). All the carbohydrates were dissolved in water and then sterilized by filtration using 0.2 micron fil-
ter size and then added to autoclaved MRS with the exception of xylan (Poly(β -D-xylopyranose[1→ 4]) 
(Sigma, Aldrich) which was autoclaved with MRS.
In the case of HMO experiments, human milk samples were kindly provided by the Western Thrust 
Human Milk Bank (Irvinestown, Co. Fermanagh, Ireland). The isolation of oligosaccharides from pooled 
samples (n ≥ 3) was performed as described previously35. Briefly, samples were defatted by centrifugation 
at 4 °C (3850 × g, 20 min, Sorvall RC6 plus® ). Caseins were precipitated at pH 4.6. After neutralization, 
large peptides were removed by ultrafiltration (5 kDa molecular-weight cut-off, Millipore® Helicon S10 
Spiral Cartridge). The permeates were freeze-dried and stored at − 80 °C until further processing. To 
remove lactose and residual peptides, the extracts were re-solubilized in MilliQ® water and applied to a 
Sephadex G-25 column (Pharmacia, Uppsala, Sweden; 92 × 2.6 cm). Elution was performed with deion-
ized water (5 mL/min). Fractions were monitored for peptides according to Bradford36 and the lactose 
content was determined by HPAEC35. Fractions low in peptide- and lactose content were pooled and 
used for further characterization.
Bifidobacterial and hosts phylogenetic reconstruction. The phylogeny of the 47 was recon-
structed as described previously9,10. Phylogeny of the eukaryotic hosts was reconstructed through the 
SUPERFAMILY web tool37.
Bifidobacterial transcriptomics identification through RNAseq assays. B. biavatii, B. boum, 
B. stellenboschense, B. coryneforme, B. cuniculi, B. gallinarum and B. pseudocatenulatum were selected 
as representatives for each of the seven phylogenetic groups. These strains were grown in MRS sup-
plemented with glucose, glycogen, lactose, xylose, rhamnose, mannose, trehalose or HMO as a carbon 
source. In order to evaluate cross-feeding activities between two bifidobacterial strains, bacteria were 
co-cultivated on MRS supplemented with a particular glycan [RS2-resistant starch (Sigma, Aldrich), 
xylan (Poly(β -D-xylopyranose[1→ 4]) (Sigma, Aldrich) or glycogen (Sigma, Aldrich)], and growth was 
monitored by the evaluation of optical density at 600 nm followed by qRT-PCR using strain-specific 
primers (see below).
When growth was observed during logarithmic phase, cell pellets were resuspended in 1 ml of 
QUIAZOL (Quiagen, UK) and placed in a tube containing 0.8 g of glass beads (diameter, 106 μ m; Sigma). 
The cells were lysed by shaking the mix on a BioSpec homogenizer at 4 °C for 2 min (maximum set-
ting). The mixture was then centrifuged at 12,000 rpm for 15 min, and the upper phase containing the 
RNA-containing sample was recovered. The RNA sample was further purified by phenol extraction and 
ethanol precipitation according to an established method38. Quality and integrity of the RNA was checked 
by Agilent 2200 Tape Station Nucleic Acid System (Agilent Technologies, Palo Alto, Calif.). One hundred 
ng of total RNA was used as the starting input for RNA-Seq library preparation. Briefly, 100 ng of total 
RNA was treated with Ribo-Zero rRNA removal kit for Gram-positive bacteria (Epicentre, Madison, 
WI, U.S.A.) to remove rRNA according to the supplier’s instructions. The yield of rRNA depletion was 
checked by Agilent 2200 Tape Station Nucleic Acid System (Agilent Technologies, Palo Alto, Calif.). 
Then, rRNA-depleted RNA samples were fragmented using RNaseIII (Life Technologies, USA) followed 
by size evaluation using Experion (BioRad, UK). Whole transcriptome library was constructed using the 
Ion Total-RNA Seq Kit v2 (Life Technologies, USA). Barcoded libraries were quantified by qRT-PCR 
and each library template was amplified on Ion Sphere Particles using Ion One Touch 200 Template 
Kit v2 (Life Technologies, USA). Samples were loaded into 316 Chips and sequenced on the PGM (Life 
Technologies, USA). Sequencing reads were depleted of adapters, quality filtered (with overall quality, 
quality window and length filters) with FastqMcf (https://code.google.com/p/ea-utils/) and aligned to the 
respective bifidobacterial reference genome through BWA39 with high stringency cut-offs (99% nucleotide 
identity) in order to accurately map reads of co-cultivation datasets on the correct genome. Counts of 
reads overlapping ORFs were performed using HTSeq (http://www-huber.embl.de/users/anders/HTSeq/
doc/overview.html) and analysis of the count data was performed using the R package DESeq240. When 
the RNAseq analyses of mono-associations, DESeq2 output consists of fold induction values determined 
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as the normalized number of transcripts identified for a given gene for bacterial cells cultivated on MRS 
containing a specific carbohydrate, relative to the number of identified transcripts for that same gene 
when the strain was grown on MRS containing glucose (reference condition). In case of RNAseq anal-
ysis of bi-associations, DESeq2 output consists of fold-induction values determined as the normalized 
number of transcripts identified for a given gene for bacterial cells cultivated in mono-association relative 
to the normalized number of identified transcripts for that same gene when the strain was cultivated in 
bi-association, using MRS supplemented with the same carbohydrate for both conditions. DESeq2 data 
normalization and differential gene expression analysis are based on the negative binomial distribution, 
which takes into consideration the overall transcript abundance identified for each analysed sample40.
Evaluation of the cell density by qPCR. The co-cultivation with other bacteria was monitored by 
quantitative PCR (qPCR). The copy-number of a gene for a given strain used in the co-cultivation exper-
iments was evaluated and compared to the growth rate of each individually cultivated microorganism. 
qPCR was performed using the CFX96 system (BioRad, CA, USA). Primers used in this study are listed 
in Table S2. Each PCR reaction mix contained the following: 7.5 μ l 2× SYBR SuperMix Green (BioRad, 
CA, USA), 5 μ l of DNA dilution, each of the forward and reverse primers at 0.5 μ M and nuclease-free 
water was added to obtain a final volume of 15 μ l. PCR products were detected with SYBR Green fluo-
rescent dye and amplified according to the following protocol: one cycle of 95 °C for 3 minutes, followed 
by 39 cycles of 95 °C for 5 s and 60 °C for 20 s. Melting curve: 65 °C to 95 °C with increments of 0.5 °C/s. 
In each run, negative controls (no DNA) for each primer set were included. Standard curve was built 
using the CFX96 software (BioRad).
Bifidobacterial gene survey of human gut metagenomic and metatranscriptomic datasets. 
We surveyed the presence of bifidobacterial genes into the microbial diversity of the healthy gut of 
44 adults and nine infants. To this end we implemented a mapping-based pipeline to detect the pres-
ence and quantify the coverage of these gene categories annotated from the newly sequenced strains 
into the Illumina deep shotgun-sequenced metagenomic data sets derived from stool samples of the 
Human Microbiome Project (HMP)19 and into Illumina deep shotgun-sequenced metagenomic and 
metatranscriptomic data sets obtained from stool samples of nine healthy infants. The mapping was 
performed using BowTie241 using multiple-hit mapping and “very-sensitive” policy. The mapping was 
post-processed with a custom script to retain those matches with at least 98% full-length identity with 
respect to at least one reference gene by threshold-ing the BowTie2 score at −12 for the 100 nt-long 
adults and infant datasets (−6 is the penalty for a high-quality mismatch). Genes covered by matching 
reads for less than 90% of their full length were discarded and the final gene-wise average coverage was 
computed using SAMtools42 and BEDtools43. In the final matrices, GHs genes and genes constituting 
carbohydrate-degrading pathways were collapsed into GH families and MetaCyc pathways. The estima-
tion of the relative abundance of bifidobacteria (at the genus level) was performed with MetaPhlAn34.
Data Deposition. The RNAseq data were deposited in SRA database under the following study acces-
sion numbers: PRJNA239567 and PRJNA277297.
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